The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

Completed

Conditions studied: Autoimmune Pulmonary Alveolar Proteinosis

In brief

The major goal of this study is to conduct a prospective, longitudinal study of autoimmune PAP to examine outcome measures for disease severity of potential use in clinical practice and/or clinical research studies. These results will impact the field by: 1) improving an understanding of the clinical course of autoimmune PAP, 2) providing information on various clinical outcome and quality of life outcome measures to guide patients and physicians in making treatment choices, and 3) facilitate the development of pharmaco-therapeutics for autoimmune PAP and 4) better informing PAP researchers.

Key facts

Study ID

NCT03531996

Run by

Children's Hospital Medical Center, Cincinnati

People needed

29

Starts

2018-04-19

Expected to finish

2020-09-16

Last updated by the study team

2021-06-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent must be provided by:
• Participant if at least 18 years old -OR-
• Parent/legal guardian if participant is less than 18 years old -AND-
• Participant provides assent when appropriate
• History of diagnosis of autoimmune as indicated by a:
• History of chest CT or x-ray findings compatible with PAP -AND-
• History of a Positive (Abnormal) serum GMAb test

You may not qualify if…

• Individuals who have a serious medical illness that, in the opinion of the investigator, is likely to interfere with completion of the study will be excluded.

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.